Imaging Biometrics Ltd. (LON:IBAI)

Market Cap	1.11M -53.6%
Revenue (ttm)	699.86K -9.2%
Net Income	-142.45K
EPS	-0.00
Shares Out	246.71M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,111
Average Volume	102,607
Open	0.4899
Previous Close	0.4750
Day's Range	0.4500 - 0.4899
52-Week Range	0.4000 - 1.4000
Beta	0.79
RSI	25.53
Earnings Date	May 1, 2026

About Imaging Biometrics

Imaging Biometrics Ltd., through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, Switzerland, European Union, and the United States. It operates through Holding Company, Medical Software, and Oral Gallium Maltolate (GaM) segments. The company develops ready-to-use software applications for the healthcare industry comprising IB Clinic for all IB software platforms; IB Neuro, a MR DSC perfusion processing platform; IB Delta Suite, which creates Delta T1 maps from routin...

• Industry: Medical - Healthcare Information Services
• Sector: Healthcare
• Founded: 1965
• Employees: 7
• Stock Exchange: London Stock Exchange
• Ticker Symbol: IBAI

Financial Performance

In 2024, Imaging Biometrics's revenue was 750,105, an increase of 23.09% compared to the previous year's 609,390. Losses were -327,103, -47.56% less than in 2023.